Skip to main content
. 2021 Dec 16;13(24):6333. doi: 10.3390/cancers13246333

Figure 2.

Figure 2

Endoscopic responses following contact X-ray brachytherapy of three patients. (A) Regrowth following chemoradiotherapy (50 Gy/25 fractions) for a cT3N0M0 rectal tumor before contact X-ray brachytherapy; (B) partial response showing a deep ulcer three months following contact X-ray brachytherapy (90 Gy/3 fractions); (C) endoscopic complete response six months following treatment; (D) residual tumor following radiotherapy (25 Gy/5 fractions) for a cT2N1M0 rectal tumor before contact X-ray brachytherapy; (E) partial response showing a deep ulcer three months following contact X-ray brachytherapy (90 Gy/3 fractions); (F) partial response showing a healing ulcer six months following treatment; (G) residual lesion of 4 cm following high-dose-rate brachytherapy for a cT2N0M0 rectal tumor before contact X-ray brachytherapy to achieve symptom control; (H) partial response showing a deep ulcer three months following contact X-ray brachytherapy (60 Gy/2 fractions); (I) sustained partial response showing a deep ulcer six months following treatment.